Location: New York, NY
CIK: 0001766721 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 5, 2026
Total Value: $476M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma Inc. (BBIO) | 5,089,611 | $378M | 79.4% | $40.43 | +84.2% | COM | 10806X102 |
| SNDX | Syndax Pharmaceuticals, Inc. (SNDX) | 1,316,806 | $30.76M | 6.5% | $10.41 | +99.4% | COM | 87164F105 |
| GLUE | Monte Rosa Therapeutics Inc (GLUE) | 1,555,664 | $25.59M | 5.4% | $20.38 | +1.4% | COM | 61225M102 |
| BCAX | Bicara Therapeutics Inc. (BCAX) | 568,919 | $11.32M | 2.4% | $25.50 | -36.1% | COM | 055477103 |
| BBOT | BridgeBio Oncology Therapeutics (BBOT) | 1,018,018 | $9.111M | 1.9% | $10.41 | — | COM NEW | 107924102 |
| CMPS | Compass Pathways Plc (CMPS) | 1,432,336 | $7.921M | 1.7% | $6.35 | — | SPONSORED ADS | 20451W101 |
| SRRK | Scholar Rock Holding Corporation (SRRK) | 77,031 | $3.787M | 0.8% | $34.98 | +30.0% | COM | 80706P103 |
| BMEA | Biomea Fusion Inc (BMEA) | 2,048,757 | $3.135M | 0.7% | $8.06 | -83.7% | COM | 09077A106 |
| EPRX | Eupraxia Pharmaceuticals Inc. (EPRX) | 325,000 | $2.353M | 0.5% | $8.37 | 0.0% | COM | 29842P105 |
| URGN | Urogen Pharma Ltd. (URGN) | 108,000 | $1.942M | 0.4% | $21.69 | -3.9% | COM | M96088105 |
| ACRS | Aclaris Therapeutics Inc (ACRS) | 434,455 | $1.629M | 0.3% | $10.31 | -67.7% | COM | 00461U105 |
| MRKR | Marker Therapeutics, Inc. (MRKR) | 325,370 | $423K | 0.1% | $1.80 | -4.2% | COM NEW | 57055L206 |
| OKUR | OnKure Therapeutics, Inc. (OKUR) | 88,607 | $367K | 0.1% | $15.14 | -82.0% | COM CL A | 68277Q105 |